Clobenpropit enhances anti-tumor effect of gemcitabine in pancreatic cancer

doi:10.3748/wjg.v20.i26.8545

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 26

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6955)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-8) series, Tables (1-1) series.

Item

Count

PDF

522

WORD

187

HTML

3547

Figures (1-8)

407

Tables (1-1)

274

Sum=4937

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

992

Download

1026

Sum=2018

Jul 14, 2014 (publication date) through Feb 18, 2025

Times Cited of This Article

Times Cited (14)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Jul 14, 2014; 20(26): 8545-8557
Published online Jul 14, 2014. doi: 10.3748/wjg.v20.i26.8545

Full Size Figure Download Figure

Figure 3 Effect of clobenpropit on pancreatic cancer cell proliferation was evaluated by MTS assay. A: Panc-1, B: AsPC-1. Clobenpropit showed no cytotoxicity in pancreatic cancer cells.

Citation: Paik WH, Ryu JK, Jeong KS, Park JM, Song BJ, Lee SH, Kim YT, Yoon YB. Clobenpropit enhances anti-tumor effect of gemcitabine in pancreatic cancer. World J Gastroenterol 2014; 20(26): 8545-8557
URL: https://www.wjgnet.com/1007-9327/full/v20/i26/8545.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i26.8545